Quantification of CDR1 Gene Expression in Fluconazole Resistant Candida Glabrata Strains Using Real-time PCR
,
Abstract
Background: The opportunistic fungi, particularly Candida glabrata has been known as main etiologic agents of life-threating infections in some patients. Although fluconazole is the most effective antifungal agent against candidiasis, C. glabrata, fluconazole-resistant strains have been increased recently overexpression or mutations of ATP-binding cassette (ABC) transporter family membrane proteins such as; Cg CDR1, Cg CDR2 are responsible for fluconazole resistance in a large proportion of candidiasis cases. The aim of this study was to evaluate CDR1 gene expression level as one of main mechanism involved in this resistance using.
Methods: Candida glabrata strains were collected from various clinical samples in hospitals of Tehran in 2015 . After validation of all isolates by conventional and molecular methods, the susceptibility analysis to fluconazole of all isolates was performed using CLSI broth microdilution M27-A3 and M27-S4 protocols. Two isolates have been selected based on difference in susceptibility and CDR1-mRNA expression level of isolates was measured by Real-time PCR method.
Results: Susceptibility results revealed that 32%, 64% and 4% of strains were susceptible, dose-dependent (DD) and resistant to fluconazole respectively. Furthermore, resistance strain of C. glabrata (MIC≥64 µg/ml) showed overexpression of CDR1 compared with sensitive strain in Real-time PCR analysis.
Conclusion: Thus, it is necessary to investigate the functions of CgCDR1 genes as a transporter-related gene.
Blumberg HM, Jarvis WR, Soucie JM, et al (2001). Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis, 33:177-186.
Diekema DJ, Pfaller MA (2004). Nosocomial candidemia: an ounce of prevention is better than a pound of cure. Infect Control Hosp Epidemiol, 25:624-626.
Eggimann P, Garbino J, Pittet D (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet, 3:685-702.
Fesharaki SH, Haghani I, Mousavi B, et al (2013). Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. J Med Microbiol, 62(Pt 11):1763-7.
Afsarian SMH, Badali H, Shokohi T, Najafipour S (2015). Molecular Diversity of Candida albicans Isolated from Immunocompromised Patients, Based on MLST Method. Iran J Public Health, 44:1262-69.
Marr KA, Seidel K, White TC, Bowden RA (2000). Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis, 181:309-16.
Malani PN, Bradley SF, Little RS, Kauffman CA (2001). Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses, 44:446-9.
Calderone RA, Clancy CJ (2011). Candida and candidiasis. ed. American Society for Microbiology Press.
Sanglard D, Ischer F, Bille J (2001). Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother, 45:1174-83.
Redding S, Smith J, Farinacci G, et al (1994). Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 18:240-2.
Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J (1999). The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents. Antimicrob Agents Chemother, 43:2753-2765.
Niimi M, Nagai Y, Niimi K, et al (2002). Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J Chromatogr B Analyt Technol Biomed Life Sci, 782:245-252.
Sanguinetti M, Posteraro B, Fiori B, et al(2005). Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother, 49:668-79.
Torelli R, Posteraro B, Ferrari S, et al (2008). The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrata. Mol Microbiol, 68:186-201.
Jia X-M, Ma Z-P, Jia Y, et al (2008). RTA2, a novel gene involved in azole resistance in Candida albicans. Biochem Biophys Res Commun, 373:631-6.
Redding SW, Kirkpatrick WR, Saville S, et al (2003). Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J Clin Microbiol, 41:619-22.
William E. Dismukes Md, Peter G. Pappas Md, Jack D. Sobel Md (2003). Clinical mycology. ed. OXFORD University Press, New York.
Mohammadi R, Badiee P, Badali H, et al (2015). Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res, 4:95.
Cantón E, Espinel-Ingroff A, Pemán J (2009). Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev Anti Infect Ther, 7:107-19.
Yoo JI, Choi CW, Lee KM, Lee YS (2010). Gene Expression and Identification Related to Fluconazole Resistance of Candida glabrata Strains. Osong Public Health Res Perspect, 1:36-41.
Holmes AR, Lin Y-H, Niimi K, et al (2008). ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother, 52:3851-62.
Abbes S, Mary Ch, Sellami H, et al (2013). Interactions between copy number and expression level of genes involved in fluconazole resistance in Candida glabrata. Front Cell Infect Microbiol, 3: 74.
Poláková S, Blume C, Zárate JÁ, et al (2009). Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata. Proc Natl Acad Sci U.S.A, 106:2688-2693.
Muller H, Thierry A, Coppée J-Y, et al (2009). Genomic polymorphism in the population of Candida glabrata: gene copy-number variation and chromosomal translocations. Fungal Genet Biol, 46:264-276.
Perea S, López-Ribot JL, Kirkpatrick WR, et al (2001). Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother, 45:2676-84.
Calabrese D, Bille J, Sanglard D (2000). A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology, 146:2743-54.
| Files | ||
| Issue | Vol 46 No 8 (2017) | |
| Section | Original Article(s) | |
| Keywords | ||
| Candida glabrata CDR1 Fluconazole resistance Real-time PCR | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
